<DOC>
	<DOCNO>NCT00076336</DOCNO>
	<brief_summary>This research study conduct compare safety effectiveness investigational medication , LdT ( Telbivudine ) versus Lamivudine , drug currently approve US , European Asian Health Authorities treatment Hepatitis B infection . The result patient take LdT compare result patient take lamivudine .</brief_summary>
	<brief_title>Telbivudine Versus Lamivudine Adults With Decompensated Chronic Hepatitis B Evidence Cirrhosis</brief_title>
	<detailed_description>Multicenter , multinational , randomize , double-blind study design compare safety efficacy telbivudine ( 600 mg/day ) versus lamivudine ( 100 mg/day ) 104 week adults decompensated chronic hepatitis B evidence cirrhosis . Patients pre-stratified screen Child-Turcotte-Pugh score ( CTP score &lt; 9 â‰¥ 9 ) ALT level ( within normal limit ( WNL ) &gt; 1.0 x ULN ) help assure similar degree hepatic insufficiency liver inflammation treatment arm . After 104 week treatment , participant followed-up additional 16 week .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Telbivudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Documented decompensated chronic hepatitis B define follow : 1 . Clinical history compatible decompensated chronic hepatitis B related cirrhosis ; 2 . ChildTurcottePugh score &gt; 7 point . Evidence hepatic cirrhosis portal hypertension . Other protocoldefined inclusion criterion may apply . Patient pregnant breastfeeding . Patient coinfected hepatitis C virus ( HCV ) , hepatitis D virus ( HDV ) , Human immunodeficiency virus ( HIV ) . Patient previously receive lamivudine , adefovir , investigational antihepatitis B virus ( HBV ) nucleoside nucleotide analog time Patient receive interferon immunomodulatory treatment HBV infection 12 month Screening study . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>